Atossa Therapeutics Financials
| YAG2 Stock | EUR 1.15 0.04 3.60% |
Atossa |
Understanding current and past Atossa Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Atossa Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Atossa Therapeutics' assets may result in an increase in income on the income statement.
Atossa Therapeutics Stock Summary
Atossa Therapeutics competes with AVITA Medical, Boston Beer, UNITED RENTALS, Microbot Medical, and ScanSource. Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. ATOSSA THERAPEU operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US04962H5063 |
| Business Address | 107 Spring Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.atossatherapeutics.com |
| Phone | 206 588 0256 |
| Currency | EUR - Euro |
You should never invest in Atossa Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Atossa Stock, because this is throwing your money away. Analyzing the key information contained in Atossa Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Atossa Therapeutics Key Financial Ratios
There are many critical financial ratios that Atossa Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Atossa Therapeutics reports annually and quarterly.| Return On Equity | -0.18 | |||
| Return On Asset | -0.11 | |||
| Target Price | 7.75 | |||
| Beta | 1.27 |
Atossa Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Atossa Therapeutics's current stock value. Our valuation model uses many indicators to compare Atossa Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atossa Therapeutics competition to find correlations between indicators driving Atossa Therapeutics's intrinsic value. More Info.Atossa Therapeutics is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atossa Therapeutics' earnings, one of the primary drivers of an investment's value.Atossa Therapeutics Systematic Risk
Atossa Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Atossa Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Atossa Therapeutics correlated with the market. If Beta is less than 0 Atossa Therapeutics generally moves in the opposite direction as compared to the market. If Atossa Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Atossa Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Atossa Therapeutics is generally in the same direction as the market. If Beta > 1 Atossa Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Atossa Therapeutics November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Atossa Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Atossa Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Atossa Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Atossa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Atossa Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 15.42 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 5.51 |
Complementary Tools for Atossa Stock analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |